New report: Impact, outlook for investors in wake of marijuana vape crisis

Be at the forefront of cannabis and psychedelics science and innovation. Register by March 14 & Save $100 on tickets to The Emerald Conference by MJBiz Science, April 1-3 in San Diego.


Vaporizer products – for both nicotine and THC – have dominated many headlines across the United States in recent weeks, with vaping being blamed for several deaths and severe illnesses.

While the exact cause is still unclear, the impact is being felt broadly in the cannabis industry, and investors are concerned how it may impact their portfolios.

This report takes a closer look at the vape segment of cannabis and provides a framework to assess the downside risk and upside potential of stocks with significant exposure to the sector, including:

  • Which companies are most exposed to the vape market.
  • How the crisis impacts the broader cannabis industry.
  • The potential outcomes for the market and investors into it.
  • Which companies might benefit.

Learn more and access the report, an exclusive benefit for subscribers to MJBizDaily’s Investor Intelligence, here.